Press Releases

Monsoon brings great relief for most people. With the showers bringing about the much-needed respite from the intense heat of the summers, for those with asthma, it is an ordeal as it worsens their condition. The seasonal exacerbation of asthma is a well-known phenomenon. Asthma is a disease that can be triggered with an allergic reaction from allergens, such as mould/fungus, furry pet, dust mites, and viral infection. Monsoon being one of the major triggers. Less sunlight during the rainy se

Pharming Group N.V. announces it has entered into an exclusive licence agreement with NewBridge Pharmaceuticals ("NewBridge") for the distribution of RUCONEST® (conestat alfa) in the Middle East and North Africa ("MENA"). NewBridge, headquartered in Dubai, United Arab Emirates, is a regional specialty company, with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech

Agilent Technologies Inc. announced that the company’s PD-L1 IHC 22C3 pharmDx assay is now labeled for expanded use in patients with non-small cell lung cancer (NSCLC) in the European Union. PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) 50% for treatment with Libtayo® (cemiplimab). This announcement underscores Agilent's continuing commitment to the development of IHC-based diagnostics f

On 9 November 2021, the 18th Annual CPhI Pharma Awards will take place in Milan, Italy at the Stella Polare Convention Centre. The CPhI Pharma Awards celebrate innovators and thought leaders breaking new ground in the pharma and biopharma industries, and their commitment to advancing new approaches, processes and technologies. Held as part of CPhI Worldwide (9-11 November 2021), the world’s largest pharma exhibition, these prestigious awards recognise the individuals, teams an

UK-based software provider to the life science industry, Veratrak, has announced its partnership with French contract development and manufacturing organisation (CDMO) Skyepharma. Skyepharma is a fully integrated CDMO offering early formulation development, scale up, manufacturing and packaging of classic and complex oral solid dosage forms. The company has selected Veratrak’s platform to ensure data integrity and enable secure data sharing throughout its supply chai

Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, celebrated the opening of Project Tomorrow—the company’s new, state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin. Wisconsin Governor Tony Evers and U.S. Representative Bryan Steil (WI-01) attended the Project Tomorrow Grand Opening event. “Today marks another milestone in our company’s continued mission to manufacture specialty and generi

Eisai Co., Ltd. announced that its Thailand subsidiary Eisai (Thailand) Marketing Co., Ltd. has launched the bile acid transporter inhibitor Goofice (generic name: elobixibat hydrate) in Thailand. This is the first launch of Goofice in the Asian region excluding Japan. Goofice, which Eisai's subsidiary for gastrointestinal diseases EA Pharma Co., Ltd. (Tokyo, "EA Pharma"), in-licensed from Albireo AB (Sweden), is a once-daily, orally available constipation treatment wi

Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India. Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions. This partnership is focused on accelerating Sky

Ipsen and IRLAB announced the signing of a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. Mesdopetam is being assessed in Phase IIb clinical trials as a potential treatment option for people living with Parkinson’s disease (PD) experiencing levodopa-induced dyskinesia (LID). It is estimated that approximately 40-50 percent of people living with PD will experience LID after five years of i

SP Scientific Products (SP) announces that it has expanded its freeze dryer loader range with the launch of two new fully GMP compliant loading systems compatible with SP Hull LyoConstellationTM freeze dryers. Designed for advanced aseptic pharmaceutical processes involving lyophilization, SP’s latest loader introductions offer flexible and innovative solutions for small to medium batch and high-speed full line aseptic vial handling applications. The two latest SP H